chr19-7633409-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_174895.3(PCP2):āc.49G>Cā(p.Glu17Gln) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000319 in 1,569,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_174895.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCP2 | NM_174895.3 | c.49G>C | p.Glu17Gln | missense_variant, splice_region_variant | 1/4 | ENST00000311069.6 | NP_777555.1 | |
PCP2 | XM_024451346.2 | c.212G>C | p.Arg71Pro | missense_variant, splice_region_variant | 1/5 | XP_024307114.1 | ||
STXBP2 | NM_001414484.1 | c.-60+2563C>G | intron_variant | NP_001401413.1 | ||||
PCP2 | XM_006722639.4 | c.-60-579G>C | intron_variant | XP_006722702.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCP2 | ENST00000311069.6 | c.49G>C | p.Glu17Gln | missense_variant, splice_region_variant | 1/4 | 1 | NM_174895.3 | ENSP00000310585.4 | ||
ENSG00000268400 | ENST00000698368.1 | n.114+2750C>G | intron_variant | ENSP00000513686.1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151438Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000224 AC: 4AN: 178782Hom.: 0 AF XY: 0.0000105 AC XY: 1AN XY: 95454
GnomAD4 exome AF: 0.00000282 AC: 4AN: 1417634Hom.: 0 Cov.: 31 AF XY: 0.00000143 AC XY: 1AN XY: 701060
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151438Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 73982
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 12, 2024 | The c.49G>C (p.E17Q) alteration is located in exon 1 (coding exon 1) of the PCP2 gene. This alteration results from a G to C substitution at nucleotide position 49, causing the glutamic acid (E) at amino acid position 17 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at